Viking Therapeutics plans USD 200 million convertible senior notes offering due 2032
Bitget2026/09/23 20:33- Viking Therapeutics launched a public offering of USD 200 million convertible senior notes due 2032.
- Underwriters hold a 30-day option to buy up to an additional USD 30 million of the notes for over-allotments.
- Notes to mature Oct. 15, 2032; senior unsecured; interest payable semi-annually; conversion settled in cash, shares, or both.
- Redemption allowed from Oct. 22, 2029 if shares trade above 130% of the conversion price for a specified period.
- Proceeds earmarked for development and commercialization of VK2735, advancement of VK3019, working capital, and general corporate purposes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
